title: Deal watch: AbbVie invests in pioneering celiac disease therapy.
authors.forename: Sarah
authors.initials: S
authors.lastname: Crunkhorn
mesh_terms: D002446:Celiac Disease / Q000188:drug therapy* / Q000276:immunology; D017322:Clinical Trials, Phase II as Topic / Q000191:economics; D017326:Clinical Trials, Phase III as Topic / Q000191:economics; D015195:Drug Design; D004345:Drug Industry / Q000191:economics* / Q000639:trends; D006801:Humans; D007449:Investments; D010447:Peptide Hydrolases / Q000009:adverse effects / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D014481:United States
chemical_list: C571240:ALV003; D010447:Peptide Hydrolases